Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $183.86 USD
Change Today +3.09 / 1.71%
Volume 1.5M
As of 5:20 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

ALXN

Industry Average

Ratio data TTM as of 03/31/2015

Profitability - alexion pharmaceuticals inc (ALXN)

Return on Assets

Industry Comparison
13.24%

Return on Equity

Industry Comparison
18.94%

Return on Capital

Industry Comparison
15.85%

Margin Analysis - alexion pharmaceuticals inc (ALXN)

Gross Margin

Industry Comparison
90.72%

Levered Free Cash Flow Margin

Industry Comparison
20.58%

EBITDA Margin

Industry Comparison
38.23%

SG&A Margin

Industry Comparison
30.34%

Asset Turnover - alexion pharmaceuticals inc (ALXN)

Total Assets Turnover

Industry Comparison
0.6x

Accounts Receivables Turnover

Industry Comparison
5.0x

Fixed Assets Turnover

Industry Comparison
6.9x

Inventory Turnover

Industry Comparison
1.4x

Credit Ratios - alexion pharmaceuticals inc (ALXN)

Current Ratio

Industry Comparison
4.9x

Quick Ratio

Industry Comparison
4.1x

Long-Term Solvency - alexion pharmaceuticals inc (ALXN)

Total Debt/Equity

Industry Comparison
4.56%

Total Liabilities/Total Assets

Industry Comparison
20.34%

Growth Over Prior Year - alexion pharmaceuticals inc (ALXN)

Total Revenue

Industry Comparison
27.45%

Tangible Book Value

Industry Comparison
45.12%

EBITDA

Industry Comparison
24.62%

Gross Profit

Industry Comparison
27.54%

Receivables

Industry Comparison
11.86%

Inventory

Industry Comparison
38.32%

Diluted EPS Before Extra

Industry Comparison
76.51%

Capital Expenditures

Industry Comparison
323.37%

Cash From Ops.

Industry Comparison
65.36%

Levered Free Cash Flow

Industry Comparison
8.96%
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $183.86 USD +3.09

ALXN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Croda International PLC 2,778 GBp +26.00
Dr Reddy's Laboratories Ltd 3,574 INR +14.15
Sigma-Aldrich Corp $139.44 USD +0.09
Symrise AG €56.09 EUR +0.346
United Therapeutics Corp $172.93 USD -1.02
View Industry Companies
 

Industry Analysis

ALXN

Industry Average

Valuation ALXN Industry Range
Price/Earnings 61.9x
Price/Sales 15.9x
Price/Book 10.3x
Price/Cash Flow 69.3x
TEV/Sales 17.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.